Virginia Cancer Specialists, PC, Arlington
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Blacksburg
Virginia Cancer Specialists, PC, Fairfax
e altri 12

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07222800

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NEXT Oncology Virginia, Fairfax

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07277413

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

UVA Comprehensive Cancer Center, Charlottesville
UVA Health Fontaine Research Park, Charlottesville
University of Virginia, Charlottesville
e altri 1

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07222566

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

NEXT Oncology, Fairfax

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07612176

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Charlottesville
Research Site, Fairfax
Research Site, Midlothian
e altri 2

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Virginia Cancer Specialists, Fairfax

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07007559

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

NEXT Oncology - Virginia Cancer Specialists, Fairfax

In reclutamentoFase 1/2

Età 12 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT05118789

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

USO - Virginia Oncology Associates, Norfolk

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Virginia Cancer Specialists, Fairfax

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07174336

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NEXT Oncology Virginia, Fairfax

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06128551

A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

NEXT Virginia, Faifax

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07693751

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Next Oncology Virginia Cancer Specialist, Fairfax

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07629960

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Blacksburg
Virginia Cancer Specialists, PC, Fairfax
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Low Moor
e altri 3

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT07227415

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

NEXT Oncology, Fairfax

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT06440005

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

Research Site, Midlothian

In reclutamentoFase 3

Età da 18 a 130 · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07647328

NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies

NEXT, Fairfax

In reclutamentoFase 1

Età 19 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07563829

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

University of Virginia Health System, Charlottesville
USO - Virginia Cancer Specialists, Fairfax
VCU Health Adult Outpatient Pavillion, Richmond

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

USO-Virginia Cancer Specialists, PC, Fairfax

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06561685

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

University of Virginia Cancer Center, Charlottesville
VCU Massey Comprehensive Cancer Center, Richmond

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT06311214

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Fairfax

In reclutamentoFase 1/2

Età da 18 a 75 · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07038343

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Virginia Cancer Specialists, Fairfax

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT04913285

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Hematology-Oncology Associates of Fredericksburg, Inc, Fredericksburg

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06072612

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

NEXT Virginia, Fairfax

In reclutamentoFase 1

Età da 18 a 99 · Tutti i sessi · Aggiornato il 1 set 2026 · NCT06983743

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

NEXT Virginia, Fairfax

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT07029399

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Inova Schar Cancer Institute, Fairfax
Virginia Commonwealth University Massey Cancer Center, Richmond

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 21 ago 2026 · NCT06769698

FOG-001 in Locally Advanced or Metastatic Solid Tumors

University of Virginia, Charlottesville

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT05919264

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

Crinetics Study Site, Charlottesville
Crinetics Study Site, Fairfax

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 31 lug 2026 · NCT07129252

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Virginia Cancer Specialists, Fairfax

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 30 lug 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Research Site, Fairfax
Research Site, Falls Church
Research Site, Norfolk
e altri 2

In reclutamentoFase 3

Età 18 e oltre · Donne · Aggiornato il 29 lug 2026 · NCT07044336

A Study of ASP1002 in Adults for Treatment of Solid Tumors

NEXT Oncology Virginia, Fairfax

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 23 lug 2026 · NCT05719558

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.